| 1579965-12-0 Basic information More.. |
Product Name: | 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate | Synonyms: | 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate;Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-, 1-(dihydrogen phosphate);Ethanol,2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-,dihydrogenphosphate(ester);GSK2983559 (compound 3);GSK2983559 free acid;inhibit,THP-1 cell,RIP kinase,GSK 2983559,GSK2983559 free acid,Inhibitor,GSK-2983559,RIPK,Receptor-interacting protein kinases,GSK-2983559 free acid,GSK2983559 | CAS: | 1579965-12-0 | MF: | C21H23N4O7PS2 | MW: | 538.53 | EINECS: | 604-604-1 | Mol File: | 1579965-12-0.mol |  |
- GSK2983559 free acid
-
- US $35.00-122.00 / mg
- 2025-05-26
- CAS:1579965-12-0
- Min. Order:
- Purity: 98.61%
- Supply Ability: 10g
- GSK2983559 free acid
-
- US $35.00-122.00 / mg
- 2025-05-26
- CAS:1579965-12-0
- Min. Order:
- Purity: 98.61%
- Supply Ability: 10g
|
1579965-12-0
Recommend Suppliers |
|